Continuous glucose monitoring (CGM) represents one of the most commercially robust sectors within medical technology, ...
On October 9th, 2026, private growth equity firm Sopris Capital finalised the acquisition of medical imaging artificial ...
Europe and the UK are overhauling healthcare AI oversight, shifting from static approvals to continuous lifecycle monitoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results